1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global NSAIDs Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Ibuprofen
        1.2.3 Naproxen
    1.3 Market by Application
        1.3.1 Global NSAIDs Drug Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Drugstores
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global NSAIDs Drug Market Perspective (2017-2028)
    2.2 NSAIDs Drug Growth Trends by Region
        2.2.1 NSAIDs Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 NSAIDs Drug Historic Market Size by Region (2017-2022)
        2.2.3 NSAIDs Drug Forecasted Market Size by Region (2023-2028)
    2.3 NSAIDs Drug Market Dynamics
        2.3.1 NSAIDs Drug Industry Trends
        2.3.2 NSAIDs Drug Market Drivers
        2.3.3 NSAIDs Drug Market Challenges
        2.3.4 NSAIDs Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top NSAIDs Drug Players by Revenue
        3.1.1 Global Top NSAIDs Drug Players by Revenue (2017-2022)
        3.1.2 Global NSAIDs Drug Revenue Market Share by Players (2017-2022)
    3.2 Global NSAIDs Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by NSAIDs Drug Revenue
    3.4 Global NSAIDs Drug Market Concentration Ratio
        3.4.1 Global NSAIDs Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by NSAIDs Drug Revenue in 2021
    3.5 NSAIDs Drug Key Players Head office and Area Served
    3.6 Key Players NSAIDs Drug Product Solution and Service
    3.7 Date of Enter into NSAIDs Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 NSAIDs Drug Breakdown Data by Type
    4.1 Global NSAIDs Drug Historic Market Size by Type (2017-2022)
    4.2 Global NSAIDs Drug Forecasted Market Size by Type (2023-2028)
5 NSAIDs Drug Breakdown Data by Application
    5.1 Global NSAIDs Drug Historic Market Size by Application (2017-2022)
    5.2 Global NSAIDs Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America NSAIDs Drug Market Size (2017-2028)
    6.2 North America NSAIDs Drug Market Size by Country (2017-2022)
    6.3 North America NSAIDs Drug Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe NSAIDs Drug Market Size (2017-2028)
    7.2 Europe NSAIDs Drug Market Size by Country (2017-2022)
    7.3 Europe NSAIDs Drug Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific NSAIDs Drug Market Size (2017-2028)
    8.2 Asia-Pacific NSAIDs Drug Market Size by Country (2017-2022)
    8.3 Asia-Pacific NSAIDs Drug Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America NSAIDs Drug Market Size (2017-2028)
    9.2 Latin America NSAIDs Drug Market Size by Country (2017-2022)
    9.3 Latin America NSAIDs Drug Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa NSAIDs Drug Market Size (2017-2028)
    10.2 Middle East & Africa NSAIDs Drug Market Size by Country (2017-2022)
    10.3 Middle East & Africa NSAIDs Drug Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer NSAIDs Drug Introduction
        11.1.4 Pfizer Revenue in NSAIDs Drug Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 GSK
        11.2.1 GSK Company Detail
        11.2.2 GSK Business Overview
        11.2.3 GSK NSAIDs Drug Introduction
        11.2.4 GSK Revenue in NSAIDs Drug Business (2017-2022)
        11.2.5 GSK Recent Development
    11.3 Grunenthal
        11.3.1 Grunenthal Company Detail
        11.3.2 Grunenthal Business Overview
        11.3.3 Grunenthal NSAIDs Drug Introduction
        11.3.4 Grunenthal Revenue in NSAIDs Drug Business (2017-2022)
        11.3.5 Grunenthal Recent Development
    11.4 Bayer
        11.4.1 Bayer Company Detail
        11.4.2 Bayer Business Overview
        11.4.3 Bayer NSAIDs Drug Introduction
        11.4.4 Bayer Revenue in NSAIDs Drug Business (2017-2022)
        11.4.5 Bayer Recent Development
    11.5 Sanofi
        11.5.1 Sanofi Company Detail
        11.5.2 Sanofi Business Overview
        11.5.3 Sanofi NSAIDs Drug Introduction
        11.5.4 Sanofi Revenue in NSAIDs Drug Business (2017-2022)
        11.5.5 Sanofi Recent Development
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Detail
        11.6.2 Eli Lilly Business Overview
        11.6.3 Eli Lilly NSAIDs Drug Introduction
        11.6.4 Eli Lilly Revenue in NSAIDs Drug Business (2017-2022)
        11.6.5 Eli Lilly Recent Development
    11.7 AstraZeneca
        11.7.1 AstraZeneca Company Detail
        11.7.2 AstraZeneca Business Overview
        11.7.3 AstraZeneca NSAIDs Drug Introduction
        11.7.4 AstraZeneca Revenue in NSAIDs Drug Business (2017-2022)
        11.7.5 AstraZeneca Recent Development
    11.8 Endo
        11.8.1 Endo Company Detail
        11.8.2 Endo Business Overview
        11.8.3 Endo NSAIDs Drug Introduction
        11.8.4 Endo Revenue in NSAIDs Drug Business (2017-2022)
        11.8.5 Endo Recent Development
    11.9 Merck
        11.9.1 Merck Company Detail
        11.9.2 Merck Business Overview
        11.9.3 Merck NSAIDs Drug Introduction
        11.9.4 Merck Revenue in NSAIDs Drug Business (2017-2022)
        11.9.5 Merck Recent Development
    11.10 Depomed
        11.10.1 Depomed Company Detail
        11.10.2 Depomed Business Overview
        11.10.3 Depomed NSAIDs Drug Introduction
        11.10.4 Depomed Revenue in NSAIDs Drug Business (2017-2022)
        11.10.5 Depomed Recent Development
    11.11 Yunnan Baiyao
        11.11.1 Yunnan Baiyao Company Detail
        11.11.2 Yunnan Baiyao Business Overview
        11.11.3 Yunnan Baiyao NSAIDs Drug Introduction
        11.11.4 Yunnan Baiyao Revenue in NSAIDs Drug Business (2017-2022)
        11.11.5 Yunnan Baiyao Recent Development
    11.12 Teva
        11.12.1 Teva Company Detail
        11.12.2 Teva Business Overview
        11.12.3 Teva NSAIDs Drug Introduction
        11.12.4 Teva Revenue in NSAIDs Drug Business (2017-2022)
        11.12.5 Teva Recent Development
    11.13 J&J
        11.13.1 J&J Company Detail
        11.13.2 J&J Business Overview
        11.13.3 J&J NSAIDs Drug Introduction
        11.13.4 J&J Revenue in NSAIDs Drug Business (2017-2022)
        11.13.5 J&J Recent Development
    11.14 Allergan
        11.14.1 Allergan Company Detail
        11.14.2 Allergan Business Overview
        11.14.3 Allergan NSAIDs Drug Introduction
        11.14.4 Allergan Revenue in NSAIDs Drug Business (2017-2022)
        11.14.5 Allergan Recent Development
    11.15 Purdue
        11.15.1 Purdue Company Detail
        11.15.2 Purdue Business Overview
        11.15.3 Purdue NSAIDs Drug Introduction
        11.15.4 Purdue Revenue in NSAIDs Drug Business (2017-2022)
        11.15.5 Purdue Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global NSAIDs Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Ibuprofen
    Table 3. Key Players of Naproxen
    Table 4. Global NSAIDs Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global NSAIDs Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global NSAIDs Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global NSAIDs Drug Market Share by Region (2017-2022)
    Table 8. Global NSAIDs Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global NSAIDs Drug Market Share by Region (2023-2028)
    Table 10. NSAIDs Drug Market Trends
    Table 11. NSAIDs Drug Market Drivers
    Table 12. NSAIDs Drug Market Challenges
    Table 13. NSAIDs Drug Market Restraints
    Table 14. Global NSAIDs Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global NSAIDs Drug Market Share by Players (2017-2022)
    Table 16. Global Top NSAIDs Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAIDs Drug as of 2021)
    Table 17. Ranking of Global Top NSAIDs Drug Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by NSAIDs Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players NSAIDs Drug Product Solution and Service
    Table 21. Date of Enter into NSAIDs Drug Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global NSAIDs Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global NSAIDs Drug Revenue Market Share by Type (2017-2022)
    Table 25. Global NSAIDs Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global NSAIDs Drug Revenue Market Share by Type (2023-2028)
    Table 27. Global NSAIDs Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global NSAIDs Drug Revenue Market Share by Application (2017-2022)
    Table 29. Global NSAIDs Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global NSAIDs Drug Revenue Market Share by Application (2023-2028)
    Table 31. North America NSAIDs Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America NSAIDs Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe NSAIDs Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe NSAIDs Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific NSAIDs Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific NSAIDs Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America NSAIDs Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America NSAIDs Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa NSAIDs Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa NSAIDs Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Pfizer Company Detail
    Table 42. Pfizer Business Overview
    Table 43. Pfizer NSAIDs Drug Product
    Table 44. Pfizer Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 45. Pfizer Recent Development
    Table 46. GSK Company Detail
    Table 47. GSK Business Overview
    Table 48. GSK NSAIDs Drug Product
    Table 49. GSK Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 50. GSK Recent Development
    Table 51. Grunenthal Company Detail
    Table 52. Grunenthal Business Overview
    Table 53. Grunenthal NSAIDs Drug Product
    Table 54. Grunenthal Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 55. Grunenthal Recent Development
    Table 56. Bayer Company Detail
    Table 57. Bayer Business Overview
    Table 58. Bayer NSAIDs Drug Product
    Table 59. Bayer Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 60. Bayer Recent Development
    Table 61. Sanofi Company Detail
    Table 62. Sanofi Business Overview
    Table 63. Sanofi NSAIDs Drug Product
    Table 64. Sanofi Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 65. Sanofi Recent Development
    Table 66. Eli Lilly Company Detail
    Table 67. Eli Lilly Business Overview
    Table 68. Eli Lilly NSAIDs Drug Product
    Table 69. Eli Lilly Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 70. Eli Lilly Recent Development
    Table 71. AstraZeneca Company Detail
    Table 72. AstraZeneca Business Overview
    Table 73. AstraZeneca NSAIDs Drug Product
    Table 74. AstraZeneca Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 75. AstraZeneca Recent Development
    Table 76. Endo Company Detail
    Table 77. Endo Business Overview
    Table 78. Endo NSAIDs Drug Product
    Table 79. Endo Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 80. Endo Recent Development
    Table 81. Merck Company Detail
    Table 82. Merck Business Overview
    Table 83. Merck NSAIDs Drug Product
    Table 84. Merck Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 85. Merck Recent Development
    Table 86. Depomed Company Detail
    Table 87. Depomed Business Overview
    Table 88. Depomed NSAIDs Drug Product
    Table 89. Depomed Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 90. Depomed Recent Development
    Table 91. Yunnan Baiyao Company Detail
    Table 92. Yunnan Baiyao Business Overview
    Table 93. Yunnan Baiyao NSAIDs DrugProduct
    Table 94. Yunnan Baiyao Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 95. Yunnan Baiyao Recent Development
    Table 96. Teva Company Detail
    Table 97. Teva Business Overview
    Table 98. Teva NSAIDs DrugProduct
    Table 99. Teva Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 100. Teva Recent Development
    Table 101. J&J Company Detail
    Table 102. J&J Business Overview
    Table 103. J&J NSAIDs DrugProduct
    Table 104. J&J Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 105. J&J Recent Development
    Table 106. Allergan Company Detail
    Table 107. Allergan Business Overview
    Table 108. Allergan NSAIDs DrugProduct
    Table 109. Allergan Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 110. Allergan Recent Development
    Table 111. Purdue Company Detail
    Table 112. Purdue Business Overview
    Table 113. Purdue NSAIDs DrugProduct
    Table 114. Purdue Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million)
    Table 115. Purdue Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global NSAIDs Drug Market Share by Type: 2021 VS 2028
    Figure 2. Ibuprofen Features
    Figure 3. Naproxen Features
    Figure 4. Global NSAIDs Drug Market Share by Application in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Drugstores Case Studies
    Figure 8. NSAIDs Drug Report Years Considered
    Figure 9. Global NSAIDs Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global NSAIDs Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global NSAIDs Drug Market Share by Region: 2021 VS 2028
    Figure 12. Global NSAIDs Drug Market Share by Players in 2021
    Figure 13. Global Top NSAIDs Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAIDs Drug as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by NSAIDs Drug Revenue in 2021
    Figure 15. North America NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America NSAIDs Drug Market Share by Country (2017-2028)
    Figure 17. United States NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe NSAIDs Drug Market Share by Country (2017-2028)
    Figure 21. Germany NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific NSAIDs Drug Market Share by Region (2017-2028)
    Figure 29. China NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America NSAIDs Drug Market Share by Country (2017-2028)
    Figure 37. Mexico NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa NSAIDs Drug Market Share by Country (2017-2028)
    Figure 41. Turkey NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Pfizer Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 44. GSK Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 45. Grunenthal Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 46. Bayer Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 47. Sanofi Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 48. Eli Lilly Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 49. AstraZeneca Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 50. Endo Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 51. Merck Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 52. Depomed Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 53. Yunnan Baiyao Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 54. Teva Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 55. J&J Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 56. Allergan Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 57. Purdue Revenue Growth Rate in NSAIDs Drug Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed